[HTML][HTML] The next phase of human gene-therapy oversight
FS Collins, S Gottlieb - New England Journal of Medicine, 2018 - Mass Medical Soc
FS Collins, S Gottlieb
New England Journal of Medicine, 2018•Mass Medical SocThe Next Phase of Human Gene-Therapy Oversight As gene therapy continues to change,
so must the federal framework set up to oversee it. As new biotechnologies continue to
emerge, the NIH and the FDA are proposing reductions in duplicative oversight and
changes to the role of the Recombinant DNA Advisory Committee.
so must the federal framework set up to oversee it. As new biotechnologies continue to
emerge, the NIH and the FDA are proposing reductions in duplicative oversight and
changes to the role of the Recombinant DNA Advisory Committee.
The Next Phase of Human Gene-Therapy Oversight
As gene therapy continues to change, so must the federal framework set up to oversee it. As new biotechnologies continue to emerge, the NIH and the FDA are proposing reductions in duplicative oversight and changes to the role of the Recombinant DNA Advisory Committee.
The New England Journal Of Medicine